Skip to content
Head to head

Innospec vs Linde

Side-by-side on the measures that matter, with a plain-English read. Full detail: IOSP · LIN

Updated 2 minutes ago

1-year performance, rebased to 100

IOSP +11.8%LIN +24.2%
Linde edges it on the scoreable measures. Linde has the highest Quant Rating (69); Linde has done best over the past year (+25%); Linde earns the most per share.
IOSPLIN
Snapshot
SectorSpecialty ChemicalsSpecialty Chemicals
Last price75.56502.83
Change today-1.97%-1.45%
1-year return+12.1%+24.8%
Market cap$1.86B$230.84B
52-week range63.98 – 100.79384.00 – 546.40
Valuation
P/E (TTM)13.3533.39
P/E percentile, own 5-yr range6th57th
P/B1.365.86
Dividend yield2.37%1.25%
Profitability & growth
EPS (TTM)4.6714.61
Net profit (TTM)$115.03M$6.71B
Revenue (TTM)$1.87B$36.24B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)+7.2%+9.2%
Gross margin27.7%47.9%
Operating margin8.5%27.1%
Net margin7.5%19.3%
Free cash flow (TTM)$33.90M$5.08B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership100.1%88.6%
Insider activity (12mo)33 buy / 17 sell27 buy / 16 sell
Short interest (% of float)1.9%1.4%
Analyst consensus100% buy (1)94% buy / 6% hold (16)
Analyst price target$110 (+46%)$570 (+13%)
StockVane view
StockVane Quant RatingD (56)C (69)
Company
Employees2,45065,177
Founded19382017

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.